Breaking
Friday, June 19, 2026

R&D News

🌏 NMPA

NMPA breaking news and regulatory updates for BD, investors, and analysts

Showing 1–11 of 11 articles

High impact NewsJun 15, 2026

Piyush Goyal Invites Global Pharma Firms to Partner With India

4 min

Dr. Yuki Tanaka
Critical impact NewsJun 11, 2026

Blood pressure and ischemic stroke risk in dementia: nationwide cohort findings

ischemic stroke · 5 min

Dr. Yuki Tanaka
High impact NewsJun 8, 2026

Areas with Risk of Dengue: CDC map, criteria, and global reach

CDC · Dengue · 5 min

Dr. Yuki Tanaka
High impact NewsJun 3, 2026

Risen Pharma Initiates Phase 2 Trial for RP902 in Alzheimer's

FDA · Alzheimer's disease · 4 min

Dr. Yuki Tanaka
High impact NewsJun 2, 2026

Newron Pharmaceuticals to Present at Upcoming Investor Conferences

FDA · 7 min

Dr. Yuki Tanaka
High impact NewsApr 29, 2026

Arcera Life Sciences Partners with Fosun Pharma for Neurodegenerative Disease R&D Collaboration

2 min

Kenji Watanabe
High impact NewsApr 29, 2026

Samsung Bioepis Partners with ATLATL Innovation Center to Accelerate Asia-Pacific Biotech Development

2 min

Hiroshi Sato
High impact NewsApr 23, 2026

RFID Technology Market to Reach $15 Billion by 2032, Transforming Pharmaceutical Supply Chain Management

2 min

Dr. Priya Sharma
High impact NewsApr 15, 2026

Chitosan Market Surges 14.3% CAGR as KitoZyme, Primex Lead $7.6B Pharmaceutical Biopolymer Boom by 2036

2 min

Dr. Priya Sharma
High impact NewsApr 6, 2026

NMPA Grants Breakthrough Therapy Designation to Innovent's KRAS G12C Inhibitor

NMPA · advanced solid tumors · 6 min

Dr. Yuki Tanaka
High impact NewsApr 6, 2026

PMDA Accepts Shionogi Novel Influenza Drug with SAKIGAKE Designation

PMDA · Influenza treatment · 5 min

Dr. Yuki Tanaka